Equities

Pro Medicus Ltd

Pro Medicus Ltd

Actions
  • Price (EUR)127.00
  • Today's Change4.00 / 3.25%
  • Shares traded115.00
  • 1 Year change+156.05%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 16:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

Pro Medicus Ltd (PMC:FRA) set a new 52-week high during Friday's trading session when it reached 127.00. Over this period, the share price is up 155.02%.
52-week range
Today
49.60Nov 08 2023127.00Nov 08 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open124.00
High127.00
Low124.00
Bid126.00
Offer129.00
Previous close123.00
Average volume173.20
Shares outstanding104.50m
Free float51.07m
P/E (TTM)257.91
Market cap21.32bn AUD
EPS (TTM)0.7909
AUD
Annual div (ADY)0.3467
EUR
Annual div yield (ADY)0.19%
Div ex-dateSep 04 2024
Div pay-dateSep 26 2024
Data delayed at least 15 minutes, as of Nov 08 2024 16:08 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.